Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients

Clinical and Experimental Rheumatology

Volumn 28, Issue 2, 2010, Pages 158-168

  Dai, Yong ^a   Zhang, Li ^b   Hu, Chenxiao ^a   Zhang, Yanliang ^c  

^a JINAN UNIVERSITY   (China)

^b SHANTOU UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Chromatin immunoprecipitation; Histone H3 lysine 4; Rheumatoid arthritis; Systemic lupus erythematosus; Trimethylation

Indexed keywords

CADHERIN; CADHERIN 13; HISTONE H3; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RELATED PROTEIN 1B; LYSINE; MEMBRANE PROTEIN; MESSENGER RNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN MGC3329; PROTEIN SLC24A3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DENSITY GRADIENT CENTRIFUGATION; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; MALE; MICROARRAY ANALYSIS; NUCLEIC ACID ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HISTONES; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYSINE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION; YOUNG ADULT;

EID: 77952746458     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. STRAHL BD, ALLIS CD: The language of covalent histone modifications. Nature 2000; 403: 41-45
2. LACHNER M., JENUWEIN T: The many faces of histone lysine methylation. Curr Opin Cell Biol 2002; 14: 286-298
3. MARTIN C, ZHANG Y: The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005; 6: 838-849
4. RUTHENBURG AJ, ALLIS CD, WYSOCKA J: Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 2007; 25: 15-30.
5. BANNISTER AJ, KOUZARIDES T: Histone methylation: recognizing the methyl mark. Methods Enzymol 2004; 376: 269-288
6. KLOSE RG, ZHANG Y: Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 2007; 8: 307-318 (Pubitemid 46474659)
7. DUTNALL RN: Cracking the histone code: one, two, three methyls, you're out! Mol Cell 2003; 12: 3-4.
8. SANTOS-ROSA H, SCHNEIDER R, BANNISTER AJ et al.: Active genes are tri- methylated at K4 of histone H3. Nature 2002; 419: 407-411
9. SCHNEIDER R, BANNISTER AJ, MYERS FA, THORNE AW, CRANE-ROBINSON C, KOUZARIDES T: Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 2004; 6: 73-77
10. BERNSTEIN BE, KAMAL M, LINDBLAD-TOH K et al.: Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005; 120: 169-181
11. ROH TY, NGAU WC, CUI K, LANDSMAN D, ZHAO K: High-resolution genome-wide mapping of histone modifications. Nat Biotechnol 2004; 22: 1013-1016
12. BANNISTER AJ, KOUZARIDES T: Histone methylation: recognizing the methyl mark. Methods Enzymol, 2004; 376: 269-288
13. FRAGA MF, BALLESTAR E, VILLAR-GAREA A: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005; 37: 391-400.
14. WU J, SMITH LT, PLASS C, HUANG TH: ChIP-chip comes of age for genome-wide functional analysis. Cancer Res 2006; 66: 6899-6902
15. WU J, WANG SH, POTTER D et al.: Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. BMC Genomics 2007; 8: 131.
16. O'GEEN H, SQUAZZO SL, IYENGAR S et al.: Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs. Plos Genet 2007; 3:e89.0916-26.
17. OPEL M, LANDO D, BONILLA C et al.: Genome-wide studies of histone demethylation catalysed by the fission yeast homologues of mammalian LSD1. Plos ONE 2007; 2: e386. 1-9.
18. REN B, ROBERT F, WYRICK JJ et al.: Genomewide location and function of DNA binding proteins. Science 2000; 290: 2306-2309
19. WEINMANN AS, YAN PS, OBERLEY MJ, HUANG TH, FARNHAM PJ: Isolating human transcription factor targets coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 2002; 16: 235-244
20. MIAO F, WU X, ZHANG L, YUAN YC, RIGGS AD, NATARAJAN R: Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem 2007; 282: 13854-13863
21. KONDO Y, SHEN L, YAN PS, HUANG TH, ISSA JP: Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. Proc Natl Aced Sci 2004; 101: 7398-7403
22. KONDO Y, SHEN L, CHENG AS et al.: Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008; 40: 741-750
23. BALLESTER E, ESTELLER M, RICHARDSON BC: The epigenetic face of systemic lupus erythematosus. J Immunol 2006; l15: 7143-7147
24. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324
25. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277
26. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH: : Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640
27. HUEBERT DJ, KAMAL M, O'DONOVAN A, BERNSTEIN BE: Genome-wide analysis of histone modifications by ChIP- on-chip. Methods 2006; 40: 365-369
28. FENG MIAO, RAMA NATARAJAN: Mapping global histone methylation patterns in the coding regions of human genes. Mol Cell Biol 2005; 25: 4650-4661
29. LIVAK KJ, SCHMITTGEN TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402-408
30. COUTURE JF, COLLAZO E, TRIEVEL RC: Molecular recognition of histone H3 by the WD40 protein WDR5. Nat Struct Mol Biol 2006; 13: 698-703.
31. WYSOCKA J, SWIGUT T, MILNE TA et al.: WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 2005; 121: 859-872
32. JENUWEIN T, ALLIS CD: Translating the histone code. Science 2001; 293: 1074-1080
33. ROH TY, CUDDAPAH S, CUI K et al.: The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci 2006; 103: 15782-15787
34. LIANG G, LIN JC, WEI V et al.: Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc Natl Acad Sci 2004; 101: 7357-7362
35. HEISLER LE, TORTI D, BOUTROS PC et al.: CpG Island microarray probe equences derived from a physical library are representative of CpG Islands annotated on the human genome. Nucleic Acids Res 2005; 33: 2952-2961
36. CLOUTIER JF, VEILLETTE A: Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and aphosphatase. J Exp Med 1999; 189: 111-121
37. CHUNG SA, CRISWELL LA: PTPN22: its role in SLE and autoimmunity. Autoimmunity. 2007; 40: 582-590
38. VANG T, MILETIC AV, BOTTINI N, MUSTELIN T: Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007; 40: 453-461
39. PIOTROWSKI P, LIANERI M, WUDARSKI M, LACKI JK, JAGODZIŃSKI PP: Contribution of the R620W polymorphism of protein tyrosine phosphatase non-receptor 22 to systemic lupus erythematosus in Poland. Clin Exp Rheumatol 2008; 26: 1099-1102
40. PETRONE A, SURACI C, CAPIZZI M et al.: The protein tyrosine phosphatase nonreceptor 22(PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care 2008; 31: 534-538
41. BOTTINI N, VANG T, CUCCA F et al.: Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006; 18: 207-213 (Pubitemid 43903283)
42. LIU CX, LI Y, OBERMOELLER-MCCORMICK LM et al.: The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distifnct properties with the LDL receptor-related protein. J Biol Chem 2001; 276: 28889-28896 (Pubitemid 37451969)
43. DELCUVE GP, RASTEGAR M, DAVIE JR: Epigenetic control. J Cell Physiol 2009; 219: 243-250
44. LAW JA, JACOBSEN SE: Molecular biology. Dynamic DNA methylation. Science 2009; 323: 1568-1569
45. IRVINE RA, LIN IG, HSIEH CL: DNA methylation has a local effect on transcription and histone acetylation. Mol Cell Biol 2002; 22: 6689-6696
46. OKITSU CY, HSIEH CL: DNA methylation dictates histone H3K4 methylation. Mol Cell Biol 2007; 27: 2746-2757 (Pubitemid 46581362)